❭ Centres and Core Facilities ❭ Other national research centres ❭

Other national research centres

Centre for Digital Life Norway (DLN)

The Centre for Advanced Cell Therapy

 
Scroll to top

Home OUS-research.no

  • Research by medical division
  • Scientific personnel
  • Research policy documents
  • Publications
  • News and events
    • News archive, ous-research.no
    • News from OUS (in Norwegian)
    • News and events from UiO
      • News, Faculty of Medicine, UiO (rss)
      • News, Faculty of Medicine, UiO (rss) - in Norwegian
      • UiO news magazine Apollon (rss)
      • Uniforum
      • Events, Faculty of Medicine, UiO
      • Disputations at UiO
      • Growth house
    • News search for OUH
    • Research seminars
  • Centres and Core Facilities
    • Core Facilities at OUS
    • Strategic research areas
    • Centres of Excellence / Research-based innovation
    • Other national research centres
      • Centre for Digital Life Norway (DLN)
  • Trials and projects related to COVID-19 and SARS CoV-2
  • Research director's office
  • Research support services

Recent publications

Published in Level 2 journals, first or last author from Oslo University Hospital.

Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB (2025)
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls
Qual Life Res (in press)
DOI 10.1007/s11136-025-04017-7, PubMed 40603678

Fleur du Pré M, Kleppa L, Dewan AE, Meling MT, Høydahl LS, Besser HA, Khosla C, Sollid LM (2025)
Peyer's patch B cells sample transglutaminase-gluten complexes and drive celiac disease autoimmunity
Gastroenterology (in press)
DOI 10.1053/j.gastro.2025.06.021, PubMed 40602545

Lindemann K, Berton D, Sehouli J, Christensen RD, Altintas S, Knudsen AØ, Heudel PE, Ataseven B, Vergote I, Lindahl G, Lebreton C, Schochter F, Auranen A, Follana P, Madsen K, Selle F, Petersson KS, Joly F, Braicu EI, Mirza MR (2025)
NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer
Gynecol Oncol, 199, 79-87 (in press)
DOI 10.1016/j.ygyno.2025.06.008, PubMed 40592025

More selected publications

Get in touch

Webmaster www.ous-research.no:

Trond Olav Berg

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)